{"database": "lobbying", "table": "lobbying_activities", "rows": [[3012309, "c75126c5-2e91-4581-9b3c-c51ba8326277", "Q2", "CAPITOL COUNSEL LLC", 313715, "EMD SERONO, INC.", 2023, "second_quarter", "PHA", "Issues regarding the availability and pricing of prescription drugs.", "HOUSE OF REPRESENTATIVES,SENATE", 50000, null, 0, 0, "2023-07-18T21:15:29-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["3012309"], "units": {}, "query_ms": 31.021751929074526, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}